SevenPlus

SevenPlus Coin is an industry level public blockchain.

7PLUS Coin is an ERC-20 utility token built on the Ethereum blockchain. It has a total supply of 200 million tokens, and becomes $ 0.1 per SV7 coin each during private and public sales.

About Yeh Group

Yeh Group is the holding company of Penn Asia with a paid-up capital of 500 million Baht a warp knitting business with its dyeing and finishing. The company is located in Thailand, the heart of Southeast Asia, only 35 km west of Bangkok. Yeh Group produces functional fabrics (intimate wear and sportswear) for the global market. The company mainly produces nylon and spandex yarn, although spandex polyester is gaining popularity as a stiff fabric. Yeh Group has worked with leading regional brands for underwear and sportswear for more than 25 years.

Penn Asia has around 350 employees, while Yeh Group has around 1000 employees. Due to the outbreak of the COVID-19 pandemic, Yeh Group has paid more attention to the production of new textile materials which are highly protective with biological and chemical protection. These include new dry dye innovations and printing of microfiber face masks for medical and everyday use.

TEXTILE MEDICAL INVENTORIES

Medical textile supplies belong to a variety of materials that are strictly regulated because of their safety implications. These textile fixtures are commonly used in operating rooms or hospital wards for the hygiene and safety of staff and patients. Washable or disposable. Examples of these medical supplies include surgical gowns, hats, masks, patient drapes, and gowns of various sizes. Medical textile supplies used in hospital wards include bedding, clothing, mattresses, blankets and tissues.

Problems & Solutions

1. Poor management and tracking of health and pharmaceutical supply chains

This is a huge problem during the heat of the coronavirus pandemic. Government agencies find it very difficult to track the volume and location of important supplies. It has had a devastating effect on containing the spread of the virus and protecting the population.

Solution

The supply chains that support blockchain enable unchanging, transparent and efficient tracking of medical supplies from the point of production to the consumer. Throughout the supply chain, blockchain helps provide information, transparency, evidence, accuracy. with this information, the risks associated with the supply chain will be a minimum for all parties; inclusive producers and consumers.

2. Lack of confidence and public panic

When it became known that face masks from China to Europe (UK, China, Ireland, etc.) had been contaminated, it caused panic among the population. Public panic will do more harm than good as we try to contain the outbreak of this pandemic.

Solution

A blockchain system that securely tracks and verifies materials, production volume, availability, and quality will significantly increase public confidence in ingredients and even medicines. The blockchain system will allow fact-based information sharing. Tracing the origin and end point of medical textile materials will reduce unnecessary exposure and legal risks.

3. Lack of payment facilities

Traditionally, cross-border payments have been accompanied by high banking fees and time delays due to physical distance. This is really not helping the fight to combat the spread of the coronavirus pandemic. Delays in processing transactions hinder the timely transport of medical textile materials to the places they are needed. In addition, large multinational companies find it difficult to track many business transactions and accounts financially.

Solution

To address the lack of ease of payment in the COVID-19 medical supply kit supply chain, one can adopt a digital asset payment system to make it easier for producers and buyers. A great example of such a digital asset is the 7PLUS COIN created by the Yeh Group company.

4. Counterfeit products

The counterfeit drug market is worth $ 75 billion annually, including supplies of medical textiles. On July 24, 2020, INTERPOL reported a global seizure of counterfeit medical products related to Covid-19. Items seized included 34,000 fake and substandard face masks. At a time when supplies of standard medical textiles are essential, we cannot allow a proliferation of counterfeit goods to enter the global market.

Solution

With the decentralized and immutable logging features that blockchain offers, we are able to track each COVID-19 textile medical supply journey to verify its authenticity or deficiency.

PROGRESS & COMPETENCY

Yeh Group has made tremendous progress in the development of efficient and effective textile medical supplies. Yeh Group is currently developing protective clothing for medical staff, field workers, etc. Yeh Microfiber facial mask medical products and daily wear are designed with our dry dye technology. They provide 99% filtering efficiency and are very comfortable to wear. Yeh masks have higher breathability than N95 masks and other non-woven masks.

YEH'S GROUP TECHNOLOGY

Yeh Group uses the special Drydye waterless technology for the production of covid-19 medical textile materials. Only 6 manufacturing companies in the world use DryDye technology. However, Yeh Group is the only one with a one-stop service from yarn spinning, weaving, waterless dyeing and printing with advanced dry dyes to avoid water pollution. Apart from the advanced drydye technology, Yeh Group also uses blockchain technology in its supply chain process to enable more transparent and accurate tracking of medical textile products. The blockchain protocol allows retailers to verify the authenticity of all covid-19 medical equipment coming from the Yeh Group

Benefits

Sevenplus has paid its token holders in the form of dividends, achieving an annual dividend yield of 15%.

benefits in two parts - the bonus comes from the token sale and the other 15% from the annual dividend yield.

7plus Coin Token Allocation (SYMBOL: SV7)

7PLUS COIN was developed to enhance and promote seamless transactions between Yeh Group companies and tens of hundreds of future medical companies around the world. The companies range from leading pharmaceutical companies such as US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney / Dechra, Clinipace Worldwide and many others. 7PLUS Coin is an ERC-20 utility token built on the Ethereum blockchain. It has a total supply of 200 million tokens, and becomes $ 0.1 per SV7 coin each during private and public sales.

7PLUS COIN was developed to enhance and promote seamless transactions between Yeh Group companies and tens of hundreds of future medical companies

around the world. The companies range from leading pharmaceutical companies such as US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney / Dechra, Clinipace

Around the world and many others.

7PLUS Coin is an ERC-20 utility token built on the Ethereum blockchain. It has a total supply of 200 million tokens, and costs $ 0.1 per SV7 coin each during private and public sales.

The token symbol, represented as SV7 has the following allocations:

7plus Token Sale

The token sale will be in batches and will take place simultaneously with several marketing auctions. It will follow a two-round token sale offering period to allow investors at various stages to contribute to the token sale. The total supply token is 200,000,000, and the price per token is $ 0.1. The total funds expected to be raised are $ 20 million. The first sale will be held from 12 February 2021 to 28 February 2021. Those who buy within this period will receive a 25% bonus on their purchases. The second phase of the sale will take place between April 1, 2021 and May 31, 2021. People who buy in the first two weeks of the sale will receive a 15% bonus. If you buy within 3-4 weeks of the sale, you will receive a 10% bonus. Also, those who buy within 5-8 weeks will receive a 5% bonus. All sales will end on May 31, 2021.